National Pharmaceutical Pricing Authority (NPPA), the drug pricing regulator, has capped the price of blockbuster Hepatitis C drug 'Sofosbuvir' at Rs. 619.31 per tablet. The said drug cannot be sold for more than the newly capped price from April 1, 2016, according to a gazette notification dated March 29.
Sofosbuvir’s strip containing 28 tablets currently costs Rs. 19,800 to Rs. 25,000 (Rs. 705 to Rs. 900 for a tablet), depending on the brand name it is sold under.
Sofosbuvir brands like Gilead's Sovaldi are mostly prescribed along with drugs like Ribavarin and Daclatasavir to treat Hepatitis C genotypes 2 and 3, with type 3 being the most common genotype in patients in India.
Under the Drugs (Price Control) Amendment Order, 2016, the drug pricing watchdog has revised the ceiling price of as many as 102 other Schedule-I formulations including Sofosbuvir.
Hepatitis C kills half a million people annually and infects close to 150 million globally, according to the World Health Organization (WHO).
Sofosbuvir’s strip containing 28 tablets currently costs Rs. 19,800 to Rs. 25,000 (Rs. 705 to Rs. 900 for a tablet), depending on the brand name it is sold under.
Sofosbuvir brands like Gilead's Sovaldi are mostly prescribed along with drugs like Ribavarin and Daclatasavir to treat Hepatitis C genotypes 2 and 3, with type 3 being the most common genotype in patients in India.
Under the Drugs (Price Control) Amendment Order, 2016, the drug pricing watchdog has revised the ceiling price of as many as 102 other Schedule-I formulations including Sofosbuvir.
Hepatitis C kills half a million people annually and infects close to 150 million globally, according to the World Health Organization (WHO).
National
Pharmaceutical Pricing Authority (NPPA), the drug pricing regulator,
has capped the price of blockbuster Hepatitis C drug 'Sofosbuvir' at Rs.
619.31 per tablet. The said drug cannot be sold for more than the newly
capped price from April 1, 2016, according to a gazette notification
dated March 29.
Sofosbuvir’s strip containing 28 tablets currently costs Rs. 19,800 to Rs. 25,000 (Rs. 705 to Rs. 900 for a tablet), depending on the brand name it is sold under.
Sofosbuvir brands like Gilead's Sovaldi are mostly prescribed along with drugs like Ribavarin and Daclatasavir to treat Hepatitis C genotypes 2 and 3, with type 3 being the most common genotype in patients in India.
Under the Drugs (Price Control) Amendment Order, 2016, the drug pricing watchdog has revised the ceiling price of as many as 102 other Schedule-I formulations including Sofosbuvir.
Hepatitis C kills half a million people annually and infects close to 150 million globally, according to the World Health Organization (WHO). - See more at: http://www.indiainfoline.com/article/news-top-story/nppa-caps-hepatitis-c-drugs-price-to-rs-619-31-per-pill-116040200390_1.html#sthash.EnEupIWp.dpuf
Sofosbuvir’s strip containing 28 tablets currently costs Rs. 19,800 to Rs. 25,000 (Rs. 705 to Rs. 900 for a tablet), depending on the brand name it is sold under.
Sofosbuvir brands like Gilead's Sovaldi are mostly prescribed along with drugs like Ribavarin and Daclatasavir to treat Hepatitis C genotypes 2 and 3, with type 3 being the most common genotype in patients in India.
Under the Drugs (Price Control) Amendment Order, 2016, the drug pricing watchdog has revised the ceiling price of as many as 102 other Schedule-I formulations including Sofosbuvir.
Hepatitis C kills half a million people annually and infects close to 150 million globally, according to the World Health Organization (WHO). - See more at: http://www.indiainfoline.com/article/news-top-story/nppa-caps-hepatitis-c-drugs-price-to-rs-619-31-per-pill-116040200390_1.html#sthash.EnEupIWp.dpuf
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.